Lei Qian,Filip Surmont,Linong Ji
Lei Qian
Asia confronts a disproportionately high diabetes burden, characterized by aggressive pathophysiology and early-onset complications. For addressing this crisis, established therapeutic agents are actively leveraged across Asia via multiface...
Cardiometabolic Effects of Dual GLP-1 and Glucagon Receptor Agonists: A Systematic Review and Meta-analysis of Randomized Controlled Trials [0.03%]
胰高血糖素样肽-1受体和胰高血糖素受体激动剂的糖脂代谢效应：随机对照试验的系统评价和meta分析
Johann Roessler,Michael A Nauck,Arash Haghikia
Johann Roessler
Objective: Selective glucagon-like protein 1 receptor (GLP-1R) agonists reduce body weight and improve cardiometabolic risk factors. However, whether dual GLP-1R and glucagon receptor (GCGR) agonism modifies these cardiom...
β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes [0.03%]
口服巴瑞昔布免疫疗法治疗1型糖尿病一年后β细胞功能与糖尿病预后情况
Michelle So,Michaela Waibel,Jennifer J Couper et al.
Michelle So et al.
Objective: The Baricitinib in New-Onset Type 1 Diabetes (BANDIT) trial showed that baricitinib treatment for 48 weeks preserved β-cell function and lowered insulin requirements and glucose in recent-onset type 1 diabetes...
The U.S. National Diabetes Prevention Program Demonstrates Effectiveness With Insufficient Reach [0.03%]
美国全国糖尿病预防项目有效但覆盖范围不足
Benjamin Lalani,Nestoras Mathioudakis
Benjamin Lalani
Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring [0.03%]
血糖指标之外：进入持续葡萄糖监测的硬性结局时代
Wajd Alkabbani,Sara J Cromer,Elisabetta Patorno
Wajd Alkabbani
Defining Clinical Heterogeneity in Gestational Diabetes Mellitus: The Importance of Timing and Severity of Maternal Hyperglycemia [0.03%]
妊娠糖尿病临床异质性的定义：母体高血糖的时间和严重程度的重要性
Arianne Sweeting
Arianne Sweeting
Waist Circumference, Relative Fat Mass Index, and BMI as Classifiers of Diabetes Status: A Comparative, Cross-sectional Analysis in 82 Low- and Middle-Income Countries [0.03%]
腰围、相对脂肪量指数和BMI在低收入和中等收入国家糖尿病筛查中的价值：一项横断面研究
Jacqueline A Seiglie,Till Seuring,Felix Teufel et al.
Jacqueline A Seiglie et al.
Objective: Waist circumference-based measures can improve diabetes risk assessment beyond BMI. Yet, evidence to guide their integration into screening guidelines in low- and middle-income countries (LMICs) is limited, par...
Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations [0.03%]
Ostrominski等人的评论：在2型糖尿病和心血管疾病中，Tirzepatide与Dulaglutide或Semaglutide相比对主要心血管事件的有效性：来自两项目标试验仿真的见解
Yazhou Zhang,Jianping Liu
Yazhou Zhang
Response to Comment on Di Marco et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations [0.03%]
关于Di Marco等人的论文《代谢因素调节糖尿病与肺部改变之间联系》的评论回复
Zengbin Li,Maurizio Di Marco,Kálmán B Bódis et al.
Zengbin Li et al.